Monoamine Oxidase Inhibitors
This page covers all Monoamine Oxidase Inhibitors drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Amine oxidase [flavin-containing] A, Amine oxidase [flavin-containing] B, monoamine oxidase A.
Targets
Amine oxidase [flavin-containing] A · Amine oxidase [flavin-containing] B · monoamine oxidase A · 5-hydroxytryptamine receptor 6 · Monoamine oxidase · Mitochondrial electron transport chain; monoamine oxidase; methemoglobin reductase · monoamine oxidase A and B · Monoamine oxidase (MAO) · Mitochondrial electron transport chain; Monoamine oxidase · Monoamine oxidase A (MAO-A) and monoamine oxidase B (MAO-B)
Marketed (14)
- Humoryl · Neuroscience
- Parnate · Advanz · Neuroscience
Parnate works by blocking an enzyme that breaks down certain neurotransmitters, allowing them to stay in the brain longer. - B4 · Breath of Life International Pharma Ltd · Psychiatry
B4 is a medication that works by inhibiting the action of a specific enzyme. - Nardil · Pfizer · Neuroscience
- Actomol · Neuroscience
- Azilect · Teva · Metabolic
- Selegiline Hydrochloride · Somerset · Neuroscience
- Low dose oxelidine group · The Fourth Affiliated Hospital of Zhejiang University School of Medicine · Psychiatry/Neurology
Low-dose oxelidine acts as a monoamine oxidase inhibitor to increase neurotransmitter levels in the central nervous system. - Methylene blue (1%) · University Hospital, Strasbourg, France · Multiple (Toxicology, Psychiatry, Infectious Disease, Hematology)
Methylene blue acts as a redox agent and monoamine oxidase inhibitor, helping to restore cellular electron transport and reduce oxidative stress. - Auromid · Neuroscience
- Nardil · Pfizer · Neuroscience
- No Lutinus + transfer day 6 · Anja Bisgaard Pinborg · Psychiatry
No Lutinus is a medication that works by inhibiting the action of certain enzymes involved in the breakdown of tryptophan. - Furazol · Takeda · Neuroscience
- Provayblue · Rare Disease
Provayblue works by inhibiting the enzyme amine oxidase [flavin-containing] A, which is involved in the breakdown of certain amines in the body.
Phase 3 pipeline (4)
- FS MDPI · Teva Branded Pharmaceutical Products R&D, Inc. · Psychiatry/Neurology
FS MDPI is a monoamine oxidase inhibitor that increases levels of dopamine, norepinephrine, and serotonin in the central nervous system. - SPD476 (2.4 g) · Shire · Psychiatry/Neurology
SPD476 is a monoamine oxidase inhibitor that increases levels of dopamine, norepinephrine, and serotonin in the central nervous system. - Intravenous methylene blue administration · Seoul National University Hospital · Neurology / Psychiatry / Critical Care
Methylene blue acts as a redox agent and monoamine oxidase inhibitor that reduces oxidative stress and modulates mitochondrial function. - SPD503-AM · Shire · Psychiatry/Neurology
SPD503-AM is a monoamine oxidase inhibitor that increases levels of dopamine, norepinephrine, and serotonin in the central nervous system.
Phase 2 pipeline (4)
- Regulton · Neuroscience
Regulton works by inhibiting the enzyme monoamine oxidase, which breaks down certain neurotransmitters in the brain. - Iprazid · Neuroscience
Iproniazid works by blocking the enzyme that breaks down certain neurotransmitters, allowing their levels to increase in the brain. - Iproclozid · Neuroscience
Iproclozide works by blocking the enzyme that breaks down certain neurotransmitters in the brain, allowing their levels to increase and improve mood. - Methylene blue infusion · Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva · Oncology
A monoamine oxidase inhibitor
Phase 1 pipeline (1)
- 11C-L-deprenyl-D2 · Hoffmann-La Roche · Neurology
Selective norepinephrine reuptake inhibitor